Fundraising FoxCorrectsequence
Shanghai, CN · 2 known investors
Find your way into Correctsequence
Sign up to find every way you can get introduced to Correctsequence
- Your email: who you already know at Correctsequence, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Correctsequence team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
CorrectSequence Therapeutics develops base-editing gene therapies using its proprietary transformer Base Editor (tBE) platform to treat genetic diseases, rare diseases, and common conditions including inherited disorders, metabolic diseases, cardiovascular diseases, and cancers. The company has advanced multiple pipeline candidates into clinical and investigational stages, including programs for β-thalassemia and sickle cell disease.
Founders & leadership
陈
陈佳Founding Professor / Chief Scientific Advisor
牟
牟晓盾Chief Executive Officer
Investors · 2
Lilly Asia Ventureslisted by Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Correctsequence do?
- CorrectSequence Therapeutics develops base-editing gene therapies using its proprietary transformer Base Editor (tBE) platform to treat genetic diseases, rare diseases, and common conditions including inherited disorders, metabolic diseases, cardiovascular diseases, and cancers. The company has advanced multiple pipeline candidates into clinical and investigational stages, including programs for β-thalassemia and sickle cell disease.
- Who founded Correctsequence?
- Correctsequence was founded by 陈佳.
- Who are Correctsequence's investors?
- Correctsequence's investors include LAV, Lilly Asia Ventures.
- Where is Correctsequence headquartered?
- Correctsequence is headquartered in Shanghai, CN.